(Q43567649)

English

Phase II study of high-dose lovastatin in patients with advanced gastric adenocarcinoma

scientific article published in January 2001

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Phase II study of high-dose lovastatin in patients with advanced gastric adenocarcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1 reference

based on heuristic

inferred from title

author name string

Kim WS

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Kim MM

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Choi HJ

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Yoon SS

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Lee MH

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Park K

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Park CH

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Kang WK

8

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

81-83

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Lovastatin, a cholesterol biosynthesis inhibitor, inhibits the growth of human H-ras oncogene transformed cells in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/11291836

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell cycle-specific effects of lovastatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/11291836

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11291836

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11291836

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of cell growth by lovastatin is independent of ras function

1 reference

https://pubmed.ncbi.nlm.nih.gov/11291836

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipid metabolism as a target for brain cancer therapy: synergistic activity of lovastatin and sodium phenylacetate against human glioma cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11291836

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase

1 reference

https://pubmed.ncbi.nlm.nih.gov/11291836

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/11291836

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of chemotherapy in the treatment of advanced gastric and pancreas cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11291836

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1006481423298

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43567649&oldid=2206133131"